Ceapro

Ceapro Inc. is a Canadian biotechnology company involved in the development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. Ceapros patented process technologies include its Pressurized Gas eXpanded (PGX) technology which is a unique and disruptive technology with several key advantages over conventional drying and purification methods that can be used to process biopolymers into high-value, nano-sized polymer structures...

Natural health ingredients,agri-based specialty chemicals,platform extraction technologies,botanical actives,and personal care ingredients

Ceapro operates in the Biotechnology industry.

Ceapro's revenue is 11m - 100m

Ceapro has 11 - 50 employees.